Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]Fluciclatide PET/CT in Solid Tumors
NCT01176500Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Jul 2010
- Primary completion
- Nov 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclatide in solid tumor, sponsored by National Cancer Institute. Planned start Jul 2010; status: withdrawn.
02
Drugs
fluciclatide
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01176500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176500.